USPTO serial 97072496
ADVANCING CLINICAL RESEARCH: SAFER, SMARTER, FASTER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 29, 2022
- Examiner
- SMITH, TARYN E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ADVANCING CLINICAL RESEARCH: SAFER, SMARTER, FASTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew J. Ferren
Andrew J. Ferren GOULSTON & STORRS PC400 ATLANTIC AVENUEBOSTON, MA 02110UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting; business administrative assistance, namely, business support services for the preparation and filing of institutional biosafety committee and institutional review board forms for use in the field of human subject research; business management consultation services concerning organization transformation in the field of clinical trials involving human subjects; professional staffing services in the field of medical and scientific research; organizing and administering a network of research sites, namely, business consultation and management in the field of clinical trials, specifically, providing governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes | ACTIVE | Aug 10, 2021 |
| 036 | Financial advisory services, namely, budget negotiation and budget set-up services in the field of clinical trials involving human subjects; insurance coverage consultancy services, namely, determining whether particular goods and services in clinical trials are covered by Medicare | ACTIVE | Aug 10, 2021 |
| 041 | Providing online education, namely, providing online courses of instruction from a computer database or via the internet or extranet in the fields of clinical trials; developing, arranging, and conducting educational conferences in the field of clinical, medical, and biological research studies; educational services, namely, providing online, non-downloadable webinars, seminars, and conferences in the field of clinical, medical, and biological research studies; non-downloadable electronic publications in the nature of articles, blog posts, case studies, and e-learning modules in the field of clinical, medical, and biological research studies; developing, arranging and conducting business conferences in the field of clinical, medical, and biological research studies | ACTIVE | Aug 10, 2021 |
| 042 | Providing information in the field of medical and scientific research on the internet; providing digital content, namely, e-learning solutions in the nature of software as a service (SAAS) services featuring software for database management and information management relating to clinical trials, on the internet; providing temporary use of on-line non-downloadable software for use by clinical, medical, and biological researchers, research sponsors and clinical research organizations for use in automating the submission, review and approval process of human subject clinical research projects and providing access to forms and templates to researchers, research sponsors and clinical research organizations for automating the submission, review and approval of human subject clinical research projects; providing temporary use of non-downloadable computer software for use in healthcare and research for the management and administration of research for the protection of research participants by automating the conduct of research studies and consent of research participants; providing institutional biosafety committee services, namely, review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, evaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, testing, analysis, and evaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards; consultation services in the nature of quality management, namely, quality evaluation and analysis, quality assurance, and quality control in the field of clinical, medical, and biological research studies; consultation services in the field of drug and medical device development; consultation services in the field of conducting clinical trials for others; consultation services in the field of scientific research compliance, namely, analysis and evaluation of scientific research of others in the field of clinical trials involving human subjects to assure compliance with industry standards; consultation services in the field of scientific research administration and operations in the field of clinical trials involving human subjects; consultation services in the field of product research and development and scientific research and development; consulting services in the field of medical and scientific research for clinical trials; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff for use in the design, administration, and tracking of clinical, medical, and biological research studies; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff in the storage, analysis, and transfer of data related to clinical, medical, and biological research studies; providing online non-downloadable software for use in collecting and managing consents from participants in clinical, medical, and biological research studies; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff in regulatory reporting, compliance tracking, safety monitoring, and evaluation of clinical, medical, and biological research studies; providing online non-downloadable software enabling real-time communication for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, research site staff, and institutional review boards in clinical, medical, and biological research studies; providing online non-downloadable software for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff in managing stipends and travel reimbursements in clinical, medical, and biological research studies; providing online non-downloadable software for use by pharmaceutical companies and clinical, medical, and biological research study sponsors, and contract research organizations in the design and administration of scientific and medical research projects and of clinical trials for pharmaceuticals, medical devices and medical procedures; providing online non-downloadable software for use by pharmaceutical companies and clinical, medical, and biological research study sponsors, contract research organizations, research sites, and research site staff for data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; providing online non-downloadable software in the nature of a support platform for use by clinical, medical, and biological research study sponsors, contract research organizations, research sites, research site staff, study teams and patients for use in information management in the performance of a clinical trial; providing online non-downloadable software in the nature of a clinical trial management system for data processing and information management for use by academic medical centers and cancer centers; providing online non-downloadable software in the nature of a clinical trial management system for data processing and information management for use by clinical, medical, and biological research sites, site networks, hospitals, and health systems; providing online non-downloadable teaching software system in the nature of an e-learning apparatus support platform for content delivery, patient recruitment management, and learning process management and reporting for use by clinical, medical, and biological research site staff, study teams and patients relating to clinical trials; providing online non-downloadable software for patient identification for use by clinical, medical, and biological researchers for patients enrolled in clinical trials; providing online non-downloadable software for patient scheduling and tracking for use by clinical, medical, and biological research sites and patients enrolled in clinical trials; troubleshooting of computer software problems; providing temporary use of non-downloadable cloud-based software for transmitting clinical trial data; business technology software consultation services regarding the implementation of computer software provided online for use in healthcare and research that is for the management and administration of research, the protection of research participants, and the automation and facilitation of the conduct of research studies and electronic consent of research participants; providing online education, namely, software as a service (SAAS) services featuring e-learning software for providing online courses of instruction relating to clinical trials in the field of medicine | ACTIVE | Aug 10, 2021 |
| 045 | Providing regulatory compliance consultation services in the nature of advice concerning due diligence, strategic development, and regulatory policy in the field of clinical trials involving human subjects; providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; providing information relating to regulatory compliance for independent review of clinical trials involving human subjects; providing institutional biosafety committee services, namely, independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects; regulatory compliance consultation services in the nature of health inspection readiness and remediation in the field of clinical, medical, and biological research studies; consultation services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants; consultation services in the field of research compliance, namely, regulatory compliance consultation services in the field of clinical trials involving human subjects | ACTIVE | Aug 10, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Advarra, Inc.
- Other trademarks owned by Advarra, Inc.
- Other trademarks owned by Advarra, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named ADVANCING CLINICAL RESEARCH: SAFER, SMARTER, FASTER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 25, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 29, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 29, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 13, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 13, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 24, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 9, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 9, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 9, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2021 | NWAP | NEW APPLICATION ENTERED | — |